India Pharma Outlook Team | Tuesday, 24 February 2026
Gleneagles Hospital, Parel, Mumbai, has teamed up with Medtronic India to launch a Renal Denervation Therapy Centre for resistant hypertension treatment. The centre will offer advanced technology, expert teams, and personalized care pathways for patients struggling with high blood pressure despite multiple medications.
Led by top specialists, including Dr. Rahul Gupta, Dr. Bharat Shah, Dr. V.M. Reddy, and Dr. Prashant Rajput, the centre aims to improve blood pressure management and reduce risks of heart, brain, and kidney complications.
With hypertension rising due to modern lifestyles, stress, unhealthy diets, and lack of exercise, early diagnosis and sustained management are critical. Despite available medications, many patients face difficulties in controlling blood pressure, especially those with resistant hypertension.
The new centre will provide thorough evaluation, medication optimization, and access to renal denervation therapy, bringing together cardiologists, nephrologists, and internal medicine experts for holistic care. The team will focus on patient education, lifestyle changes, and regular follow-ups to help patients achieve long-term blood pressure control and reduce serious health risks.
Also Read: GSK Secures EU Nod for Exdensur in Severe Asthma
Dr. Rahul Gupta, Director and Cardiologist at Gleneagles Hospital, Parel, said, “Resistant hypertension is often silent but extremely dangerous because it increases the risk of heart attack, stroke, and heart failure. Many patients believe they are on treatment, yet their blood pressure remains uncontrolled. The introduction of renal denervation therapy offers an additional option for carefully selected patients whose blood pressure does not respond to medicines alone. At Gleneagles Hospital, our goal is to provide a comprehensive approach that combines lifestyle guidance, optimal medication, and advanced interventional therapies to achieve sustained blood pressure control and reduce long-term complications.”
Dr Bharat Shah, Nephrologist at Gleneagles Hospital, added, “Uncontrolled hypertension not only affects the heart but also has a serious impact on kidney health. Long-standing high blood pressure can gradually damage kidney function and may even lead to chronic kidney disease. The establishment of this specialized centre allows us to identify high-risk patients early and provide structured, multidisciplinary care. Renal denervation therapy can play an important role in selected patients by targeting overactive nerves that contribute to high blood pressure. This integrated model will help improve outcomes and prevent long-term organ damage.”
“Hypertension management continues to be challenged by delayed diagnosis, fragmented care, and inconsistent follow?up. Partnering with Medtronic enables Gleneagles Hospital to adopt a more structured and coordinated approach to resistant hypertension by integrating clinical expertise, advanced technology, and patient?centric care pathways. This collaboration is focused on achieving long?term blood pressure control and reducing the risk of cardiovascular complications, ultimately improving outcomes for patients with resistant hypertension,” concluded Dr. Bipin Chevale, CEO, Gleneagles Hospital.
Also Read: India's Innovative Therapies Set Global Standard at Low Cost
Speaking on the partnership, Mandeep Singh Kumar, Managing Director & Vice President, Medtronic India, said, “Resistant hypertension remains a growing and often unrecognized challenge in cardiovascular care, and its rising burden underscores the urgent need to reevaluate how care is delivered. Our partnership with Gleneagles Hospital Mumbai is focused on delivering real-world impact by working closely with its clinical teams to strengthen awareness and to enable a more coordinated, structured approach to its diagnosis and management. This collaboration aims to support improved blood pressure control and better long-term outcomes for patients with complex and resistant hypertension. At Medtronic, our mission is to alleviate pain, restore health, and extend life, and collaborations like this are central to that commitment.”